Join to View Full Profile
825 Eastlake Ave ESeattle, WA 98109
Phone+1 206-288-1000
Fax+1 206-606-1025
Are you Dr. Silberstein?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 7 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Lev Silberstein, MD is an oncologist in Seattle, Washington. He is currently licensed to practice medicine in Washington and Massachusetts. He is affiliated with Fred Hutch Cancer Center.
Education & Training
- Novosibirsk State Medical AcademyClass of 1993
Certifications & Licensure
- WA State Medical License 2017 - 2026
- MA State Medical License 2015 - 2016
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Publications & Presentations
PubMed
- Author Correction: Niche-derived Semaphorin 4A safeguards functional identity of myeloid-biased hematopoietic stem cells.Dorsa Toghani, Sanika Gupte, Sharon Zeng, Elmir Mahammadov, Edie I Crosse
Nature Aging. 2025-02-20 - Niche-derived Semaphorin 4A safeguards functional identity of myeloid-biased hematopoietic stem cells.Dorsa Toghani, Sanika Gupte, Sharon Zeng, Elmir Mahammadov, Edie I Crosse
Nature Aging. 2025-01-29 - 2 citationsIbrutinib response in a patient with refractory mixed essential cryoglobulinemia.Haya Jamali, David Wu, Lorinda Soma, Michael Linenberger, Mark H Wener
Ejhaem. 2023-05-01
Press Mentions
- Two Fred Hutch Postdocs Named 2021 Damon Runyon FellowsAugust 13th, 2021
Grant Support
- Extrinsic regulation of primitive, myeloid-biased hematopoietic stem cells by Semaphorin 4aFRED HUTCHINSON CANCER CENTER2021–2025
- Extrinsic regulation of primitive, myeloid-biased hematopoietic stem cells by Semaphorin 4aFRED HUTCHINSON CANCER CENTER2021–2025
- Extrinsic regulation of primitive, myeloid-biased hematopoietic stem cells by Semaphorin 4aFRED HUTCHINSON CANCER CENTER2021–2025